This information from Cancer Care Ontario / Ontario Health is a starting point for healthcare providers to find information about biosimilar drugs. It includes links to resources from the pan-Canadian Oncology Biosimilars Initiative.
Document CAPCA Initiative: Other
This information from Cancer Care Ontario / Ontario Health is a starting point for information about biosimilar drugs. It includes links to a video and other resources and organizations that provide information about biosimilars.
The Canadian Association of Provincial Cancer Agencies (CAPCA) developed the Pan-Canadian Consensus Recommendations for Proton Beam Therapy Access in Canada to improve coordination and harmonization of proton beam therapy (PBT) planning and delivery.
Intended for clinical leaders, program staff and…
These guidelines apply specifically to the use of oral cancer drug therapy in the treatment of adult cancer though we strongly believe they are broadly applicable and address important gaps and concerns regarding safe use and handling of these hazardous…
This evidence-informed consensus guideline was developed to address the safe handling of oral anti-cancer drugs (OACDs) in community pharmacies across the medication lifecycle, from manufacturer packaging to waste management and incident reporting.
The primary target audience is community pharmacy staff,…
